136 related articles for article (PubMed ID: 32507944)
1. Changing face of medication-related osteonecrosis of the jaw: Sheba Medical Center experience-fifteen years.
Whitefield S; Lazarovici TS; Sommer-Umansky M; Friedlander-Barenboim S; Yahalom R; Yarom N
J Bone Miner Metab; 2020 Nov; 38(6):819-825. PubMed ID: 32507944
[TBL] [Abstract][Full Text] [Related]
2. Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Study on the Prevalence of Cutaneous Manifestations and the Primary Care Physician's Role in its Early Diagnosis.
Whitefield S; Ilan MB; Lazarovici TS; Friedlander-Barenboim S; Kassem R; Yarom N
Am J Med; 2024 Mar; 137(3):266-272. PubMed ID: 38042241
[TBL] [Abstract][Full Text] [Related]
3. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
4. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
5. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
8. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
[TBL] [Abstract][Full Text] [Related]
9. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
10. Pain characteristics in medication-related osteonecrosis of the jaws.
Haviv Y; Geller Z; Mazor S; Sharav Y; Keshet N; Zadik Y
Support Care Cancer; 2021 Feb; 29(2):1073-1080. PubMed ID: 32601851
[TBL] [Abstract][Full Text] [Related]
11. [The risk of bisphosphonate-related osteonecrosis of the jaw].
Polymenidi I; Trombetti A; Carballo S
Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
[TBL] [Abstract][Full Text] [Related]
12. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
13. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.
Miranda-Silva W; Montezuma MA; Benites BM; Bruno JS; Fonseca FP; Fregnani ER
Support Care Cancer; 2020 Nov; 28(11):5397-5404. PubMed ID: 32144584
[TBL] [Abstract][Full Text] [Related]
14. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
15. Medical students' knowledge of medication related osteonecrosis of the jaw.
Franchi S; Brucoli M; Boffano P; Dosio C; Benech A
J Stomatol Oral Maxillofac Surg; 2020 Sep; 121(4):344-346. PubMed ID: 31672685
[TBL] [Abstract][Full Text] [Related]
16. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
[TBL] [Abstract][Full Text] [Related]
17. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
19. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
[TBL] [Abstract][Full Text] [Related]
20. Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England.
Sturrock A; Preshaw PM; Hayes C; Wilkes S
BMJ Open; 2019 Mar; 9(3):e024376. PubMed ID: 30833319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
